ABSTRACT
INTRODUCTION
Gene therapy has become increasingly instrumental in the field of medicine, therapeutics, and chemical engineering. However, the growing potential of gene therapy will not be in full blossom until the issue of efficient, specific gene delivery has been resolved. 1 Gene delivery with synthetic DNA vehicles becomes an attractive approach to gene therapy. [2] [3] [4] [5] [6] [7] [8] [9] The nonviral gene carriers, including cationic polymers, cationic peptides, and cationic lipids (liposome), have eliminated some of the limitations commonly encountered in the viral gene carrier, most notably, cellular toxicity and size restriction of the inserted genetic materials. Their gene transfer efficiency, however, is inferior to that of their viral counterparts. In addition, physical properties, such as size and surface, potentially play a critical role in their efficiency. Therefore, selected modifications that can lead to a safer, more efficient and targeted gene carrier are under way. [10] [11] [12] [13] [14] A new generation of polymers appeared recently, represented by polyamidoamine dendrimers, 6 histidylated polylysines, 7 and polyethylenimines, 8 which were shown to transfect cells efficiently even in the absence of auxiliary agents.
In fact, the cationic polymer, polyethylenimine (PEI), has been shown to be among the most efficient nonviral agents for in vitro gene transfer. [2] [3] [4] 8 This means that PEI must be able to condense DNA, packaging DNA into compact particles, allowing for the uptake of the complexes by target cells, release of the DNA from endocytotic vesicles into the cytosol, intracellular routing, transport into the nucleus, and finally the expression of the delivered gene. 15 This polymer is available in two main forms: linear and branched. The basic unit of PEI has a backbone of two carbons followed by one nitrogen atom. The branched form of PEI contain 1-, 2-, and 3-degree amines, each with the potential to be protonated. This gives PEI the attribute of serving as an effective buffer through a wide pH range. With nitrogens appearing as one of every three atoms in the PEI backbone, any benefit of branching and protonation ability quickly accumulates in relation to the overall polymer size. 14, 15 PEI has been successfully coupled to different ligands for the purpose of cell targeting. Examples of ligands extensively used include RGD peptides, 16 transferrin, or anti-CD3 antibody. 17 To this end, we aimed to improve the gene-transfer efficiency of PEI toward invading cancer cells by combining PEI covalently with antibodies against matrix metalloproteinase 2 (MMP-2) as a possible ligand specific for invading cancer cells. Our results demonstrate that the DNA complexes of the PEI-anti-MMP-2 antibody conjugate exhibited a specific, efficient gene delivery capability toward cancer cells, as opposed to the cocultured stromal cells, conferring their ability to form stable complexes with physicochemical properties favorable for cancer cell-specific gene delivery.
MATERIALS AND METHODS

Chemicals
The following chemicals were purchased from the manufacturers indicated: branched polyethyleneimine (PEI, average MW of 25 kDa, average degrees of polymerization, 580) from SigmaAldrich (St. Louis, MO); N-succinimidyl 3-(2-pyridyldithio)propionate (SPDP) and 1,4-dithiol-L-threitol (DTT) also from Sigma-Aldrich; Dulbecco's modified Eagle's medium (DMEM)-F12 medium and fetal bovine serum (FBS) from Gibco-BRL (Grand Island, NY); rabbit monoclonal antihuman MMP-2 antibodies, rabbit phycoerythrin (PE)-conjugated monoclonal antimouse vimentin antibodies and fluorescein isothiocyanate (FITC)-conjugated antirabbit IgG antibody from Santa Cruz Biotech (Santa Cruz, CA); pEGFP-N3 plasmid from Invitrogen (Carlsbad, CA); paraformaldehyde from Fluka (Cary, NC); MTT reagent (3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl tetrazolium bromide) from R&D Systems (Minneapolis, MN); YOYO-1 from Molecular Probes (Eugene, OR); all other chemicals, unless otherwise indicated, were from SigmaAldrich.
Plasmids and Cell Preparations
pEGFP-N3 (4.7 kb) encoding a red-shifted variant of wild-type green fluorescent protein (GFP), which has been optimized for brighter fluorescence and higher expression in mammalian cells, with an excitation maximum of 488 nm and an emission maximum of 507 nm, was purchased from Invitrogen and used in transfection experiments, as described below. A well-characterized human endometrial adenocarcinoma cell line HEC-1A cells were purchased from the American Type Culture Collection (ATCC HTB-112; Manassas, VA). Human endometrial stromal cells were obtained from human endometrial tissues that were isolated by curettage in a hysterectomy from the uterus of a patient who underwent a surgery at Ajou University Hospital (Suwon, South Korea), but with little symptoms of endometrial disease. Sample collections were performed after informed consent had been given and was further approved by the Institutional Review Board of Human Ethics at Ajou University Hospital. Stromal-cell-rich fractions were purified, as described previously. 18, 19 Primary stromal cells and HEC-1A cells were maintained in Dulbecco's modified Eagle's medium (DMEM)-F12 media supplemented with 10% heat-inactivated FBS at 37°C and 5% CO 2 until use.
Synthesis of the PEI-Antibody Conjugates
Anti-MMP-2 antibody was covalently conjugated to branched PEI (25 kDa) via a disulfide linkage with the heterobifunctional linker SPDP, according to the method described elsewhere, 6, 11 with a minor modification. In brief, to make the PEI sulfhydryl-terminated, 2.0 mg of purified PEI (corresponding to 10.6 mol primary amines) was dissolved in 1.0 mL of 20 mM HEPES buffer containing 0.15 M NaCl (HBS) at pH 7.9. To this solution, 100 L of 20 M SPDP was added and reacted for 1 hour. The dithiopyridine groups of PEI-SPDP complex were reduced with 3.0 mg of dithiothreitol (DTT) to offer free thiol groups on PEI. After 1 hour of disulfide reduction, thiol-modified PEI was purified with Centricon™ (Microcon ® , MWCO 10,000). Simultaneously, anti-MMP-2 antibody was modified with SPDP to attach a thiolreactive group onto the lysine residue of the antibody. SPDP (20 M in 10 L HBS) was added to 500 L anti-MMP-2 antibody (Ab) solution (100 g Ab in HBS at pH 7.9) and reacted for 1 hour at 4°C. After purification with Centricon (MWCO 10,000), thiol-terminated PEI and thiol-reactive anti-MMP-2 Ab was mixed in HBS at pH 7.4, additionally incubated for 22 hr at 4°C, and the end product was further purified with Centricon (MWCO 30,000) and lyophilized before being resuspended in HBS at pH 7.3.
Polymeric Complex Formation
The polyplex formation between plasmid DNAs and either PEI or the PEI-Ab conjugates were prepared in HBS at pH 7.3, as described elsewhere. 14, 20 Briefly, appropriate amounts of either PEI or the PEI-Ab conjugate stock solutions (each 0.1 mg/mL, pH 7.3) were diluted with serum-free media, whose pH was adjusted to 7.3 and stirred. After 10 minutes at room temperature, the diluted PEI or the PEI-Ab solution was added rapidly to the DNA solution in HBS, mixed by a vigorous vortexing, and followed by 10 minutes of incubation at room temperature before use.
Gel Retardation Assay
For the gel retardation assay, 2.0 g of plasmid DNA was mixed with increasing amounts of PEI or the PEI-Ab conjugates ranging from 0 to 8.0 g diluted in HBS at pH 7.3 and vortexed. After 10 minutes at room temperature, the resulting complex was subjected to electrophoresis. Then, 50-L aliquots of the complex solution were mixed with 5 L of loading buffer (30% glycerol, 1 mM EDTA, and 40 mM Tris/HCl; pH 7.4) and loaded onto 1% agarose gel. Electrophoresis was carried out with a voltage of 100 V for 2 hours in TAE running buffer (40 mM Tris/HCl, 1% acetric acid, and 1 mM EDTA) before visualization by ethidium bromide staining and ultraviolet (UV) illumination, as described previously. 3 
In Vitro Cytotoxicity Assay
The in vitro toxicity of PEI was tested by the MTT assay. The MTT assay was performed according to the method of Mosmann. 21 Briefly, PEI stock solutions at the appropriate concentrations were prepared in HBS (pH 7.3). Stromal cells and HEC-1A cells (each 10,000 cells/well) in DMEM-F12 plus 10% FBS were seeded onto a 96-well microplate (BD Falcon, Corning, NY). After 16 hours of cell adsorption on the plate wall, the PEI stock solution was added into the medium containing adsorbed cells at the final concentration ranging from 0.1 to 25 g/L. After 48 hours, 10 L of MTT reagent (3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl tetrazolium bromide) was added to each well and incubated for 4 hours at 37°C. When purple precipitate was clearly visible, 100 L of the detergent reagent was added to all wells in the dark and followed by a spectrophotometric measurement at 570 nm in a microplate reader, SpectraMax 190 (Molecular Devices, Sunnyvale, CA).
Size and Surface Charge Determination of Polymeric Complexes
Polymeric complexes were prepared by adding increasing amounts of PEI or the PEI-Ab conjugates to a fixed amount of pEGFP-N3 plasmid (2.0 g) in HBS (pH 7.3). Each solution was gently mixed and followed by incubation at room temperature for 15 minutes. The particle sizes and surface charges of the complexes in solution were measured by dynamic light scattering and by laser Doppler anemometry, respectively, using the Zeta Potential Analyzer (ZetaPALS; Brookhaven Inc., Brookhaven, NY).
Cell Transfection
Human primary stromal cells or HEC-1A cells were seeded at approximately 1 ϫ 10 6 cells per well in six-well plates (Costar, Corning, NY) and allowed to grow for 1 day prior to transfection. The PEI/DNA or PEI-Ab/DNA complexes were prepared by mixing 2.0 g of pEGFP-N3 plas-mids with 3.0 g of PEI or the PEI-Ab, as described above. On the day of transfection, 1.0 mL of fresh culture medium containing 10% FBS was added into each well. Then, 200 L of transfection solution consisting of PEI/DNA or PEIAb/DNA complexes at the appropriate concentration was added to each cell well. After 2 hours of incubation at 37°C, the transfection medium was replaced by fresh medium, and gene expression was measured 48 hours after the onset of transfection. The final concentration of PEI/DNA or PEI-Ab/DNA solution was adjusted below 5.0 g/L with respect to PEI to avoid any cytotoxic effect caused by PEI.
For an additional immunostaining, the transfected cells were washed several times with PBS and fixed with 4% paraformaldehyde at room temperature for 20 minutes. Cells were then pelleted and washed with 0.1 M of PBS before being incubated with cold methanol for 2 minutes at room temperature. The cells were again washed with PBS three times. The rabbit PE-conjugated antivimentin antibody solution was diluted to 1:400 in the diluent and reacted with the cells overnight at 4°C. After washing with PBS three times, the cells were observed under a confocal microscope (Olympus Fluoview FV300; Tokyo, Japan).
Flow Cytometric Analysis
The incorporation of DNA into cells was analyzed by flow cytometry, as described elsewhere. 9 In brief, human stromal cells and HEC-1A cells were cocultured for 16 hours in six-well plates at a density of 1 ϫ 10 6 cells per well in DMEM-F12 plus 10% FBS. Plasmid DNA (2 g) was mixed with the fluorophore YOYO-1 at a final concentration of 4 ϫ 10 Ϫ6 M, followed by 10 minutes of incubation in the serum-free medium. The PEI/DNA or PEI-Ab/DNA complexes were prepared, as described above, and incubated with cells for 2 hours. Cells were then suspended in PBS after detachment by the trypsin treatment for 5 minutes. Flow cytometry was performed by using a flow cytometer (FACS-Vantage; Becton Dickinson, San Jose, CA) equipped with an argon laser, with an excitation wavelength of 488 nm.
In addition, stromal cells and HEC-1A cells in coculture that were transfected with pEGFP-N3 in complex with PEI or the PEI-anti-MMP-2 antibodies were further fluorescently labeled by using PE-conjugated antivimentin antibody, as described above. The resulting cells were pelleted and resuspended in PBS prior to flow cytometric analysis.
Statistical Analysis
One-way analysis of variance (ANOVA) was used for the statistical analysis of the experiments. A value of p Ͻ 0.05 was taken as significance.
RESULTS
Synthesis of the PEI-Antibody Conjugate
The covalent conjugation of PEI to the monoclonal anti-MMP-2 Ab through a disulfide linkage was carried out by a typical conjugation chemistry, utilizing SPDP as the cross-linking agent, as outlined in Figure 1 . After purification by size-exclusion columns, as described in Materials and Methods, the resulting PEI-Ab conjugate was observed by size-and surface-charge measurements. The average diameters of PEI and the PEI-Ab conjugates in a 150-mM NaCl-containing salt solution were approximately 615 Ϯ 12 nm (n ϭ 15) and 1100 Ϯ 120 nm (n ϭ 15), respectively, as measured in dynamic light scattering (data not shown). Meanwhile, no significant surface-charge difference was noted between the PEI and the PEI-Ab conjugate, as determined by zeta potential (45 Ϯ 3 [n ϭ 15] versus 42 Ϯ 4 mV [n ϭ 15]; data not shown).
In Vitro Cytotoxicity of PEI
PEI of high molecular weight has been known to have a high toxicity toward cells. 3 In contrast, smaller molecular weight PEI polycations, branched or linear, were found to be active in vivo with a lower cytotoxicity, and particularly, linear PEI was better tolerated than branched PEI. 3 As such, the in vitro cytotoxicity of 25 kDa of branched PEI, that was subsequently used for conjugation, was tested by the MTT assay. PEI was added incrementally to cells in the serumcontaining culture medium, ranging from 0 to 25 g/L at the final concentration. After 48 hours of incubation, which is the same duration as the transfection step, its cytotoxic effects on the survival of HEC-1A cells and stromal cells were measured and represented as relative to controls (Fig. 2) . Under the experimental conditions used, the PEI exposure caused a concentration-depen-dent loss of cell viability at an IC 50 Ͻ5 g/L with a maximum decrease by as much as 87% at 10 g/L. Consequently, 0ϳ5 g/L of PEI was chosen for the following transfection experiments.
Analysis of the DNA Complexes of the PEI-Antibody Conjugates
Initially, the complexes were generated between the positively charged polymers, either PEI or the PEI-Ab conjugates, and plasmid DNAs at different charge ratios of primary amines to DNA phosphates (N/P ratios) in a physiologic salt solution (pH 7.3) and analyzed in terms of retardation of the mobility of DNA on agarose gel electrophoresis. A constant amount of plasmid DNA (2.0 g) was mixed with PEI or the PEI-Ab conjugates incrementally to evaluate the stoichiometric amount of DNA needed for the complex formation. In the presence of an excess amount of DNA, compared to PEI or the PEI-Ab conjugates, a condition also referred to as low N/P ratios, most plasmid DNA would exist in a free form, revealing three fluorescent bands ( Fig. 3 ; lane 1 in 3A and 3B) corresponding to the supercoiled and the open circular form of the plasmid, respectively, as suggested previously. 3 Adding PEI incrementally, however, caused a gradual disappearance of the bands corresponding to free plasmids (lanes 2-7 in Fig. 3A ; lanes 2-6 in Fig. 3B ). At the same time, another fraction of the plasmid DNA-indicated as a bound form-appeared, suggesting that the complexes were large in size and less negative in surface charge, which was reflected in retardation in DNA mobility. As the N/P ratio was increased further, there was a gradual decline in fluorescent intensity from the bound DNA as a result of the exclusion of ethidium bromide owing to plasmid condensation. 3 Both PEI (Fig. 3A) and the PEIAb conjugates (Fig. 3B) showed a complete condensation of DNA at approximately 4.0 g each, as evidenced by a complete disappearance of the bound DNA. Next, the complex formation between PEI or the PEI-Ab conjugates and plasmid DNA was further analyzed in dynamic light scattering and in laser Doppler anemometry. Figure 4 illustrates the diameters and the surface charges of the DNA complexes formed in HBS (pH 7.3) as a function of the amount of PEI or the PEI-Ab conjugates. For comparison, the amount of plasmid DNA was fixed at 2.0 g. The sizes of the polyplexes were varied, ranging from 170 to 400 nm for PEI (Fig.  4A) and from 230 to 445 nm for the PEI-Ab conjugate (Fig. 4B) , depending on the N/P ratios. Moreover, a decrease in particle size was observed for both the PEI and the PEI-Ab conjugates when excess cationic polymers were added, a condition also known as high N/P ratios, probably owing to enhanced condensation of DNA. However, the N/P ratio-dependent decrease in particle size became less pronounced when Ͼ2.0 g polymers, either PEI or the PEIAb conjugates, were complexed with DNA. Under the physiologic salt condition as in HBS, the size of the naked DNA was estimated to be 423 Ϯ 17 nm (n ϭ 15). For comparison, it was calculated that 3.5 g of pEGFP plasmid corresponds Effects of increasing proportion of polyethylenimine (PEI) or the PEI-antibody conjugates on the electrophoretic mobility of plasmid DNA. Two (2) g pEGFP-N3 plasmid and increasing amounts of (A) PEI or (B) the PEI-anti-metalloproteinase-2 antibody conjugates, as indicated at the bottom of each lane in micrograms, were incubated for 10 minutes, and the resulting complexes were electrophoresed through 1% agarose gel and stained with ethidium bromide to visualize DNA. to 1.0 g of 25-kDa PEI to maintain a 1:1 N/P ratio. 22 Finally, the surface charges of the polyplexes were measured by using laser Doppler anemometry. As expected, the zeta potentials of the naked DNA were strongly negative, ranging from Ϫ50 to Ϫ60 mV. However, upon forming polyplexes with PEI or the PEI-Ab conjugates, the surface charges became more positive as increasing amounts of PEI or the PEI-Ab conjugates were added, probably owing to an excess of polycations. The cross-over from negative to positive zeta potentials occurred at or near 1.5 g PEI or 1.7 g PEI-Ab conjugates, at which a 1:1 charge ratio of DNA phosphates to primary amines from the cationic polymer could be maintained (Fig.  4C and D) .
Flow Cytometric Analysis of Cancer-Specific Gene Delivery by the PEI-anti-MMP-2 Antibodies
Prelabeling of plasmid DNA with a fluorophore YOYO-1 provides a convenient means to detect DNA-containing polymers or cells by flow cytometry. Human stromal cells and/or HEC-1A cells were supplied with YOYO-1-pre-labled plasmids in complex with either PEI or the PEIAb conjugates, and the fluorescence from YOYO-1 staining was analyzed in flow cytometry. As illustrated in Figure 5 , when HEC-1A cells (Fig. 5A ) or stromal cells (Fig. 5C ) were cultured separately, the PEI-Ab conjugates caused little or negligible fluorescence intensity shift, as compared to that of PEI, as represented by the red and green lines, respectively. However, when two types of cells were cocultured, the PEI-Ab conjugates, as represented by the red line, were more effective in delivering YOYO-1-pre-labled DNA to cells than PEI. Based on this observation, it was thus postulated that cells that were more accessible by the PEI-Ab/DNA complexes might express more MMP-2 proteins on their surface. Indeed, our data on reverse transcriptase polymerase chain reaction (RT-PCR) analysis and microscopic visualization of MMP-2 expressions in stromal cells and HEC-1A cells under the coculture condition were consistent with the notion that MMP-2 is mostly synthesized by stromal cells and then transported to the surface of HEC-1A cells (data not shown; or see Park et al. 18 ). Therefore, under the coculture condition, an increasing number of HEC-1A cells become MMP-2-bearing cells, which might attract the PEI-Ab/DNA complexes more readily. To further confirm our conjecture, a second flow cytometric analysis was performed with a double fluorescence labeling: one for GFP expression owing to pEGFP-N3 transfection and the other for vimentin expression, a cellular marker for stromal cells. The percentage of vimentin-negative, GFP-positive cell populations was significantly increased from 4.21% Ϯ 1.52% to 29.37% Ϯ 5.33% (n ϭ 5) when PEI was replaced by the PEI-Ab as a gene carrier (p Ͻ 0.05 by one-way ANOVA) (Fig. 5D ).
Microscopic Visualization of Cancer-CellSpecific Gene Delivery
Cancer-cell-specific delivery of pEGFP-N3 plasmids by the PEI-Ab conjugates could be further verified by a microscopic visualization of GFP expression in HEC-1A cells. Stromal and HEC-1A cells were cocultured before being transfected with pEGFP-N3 plasmids in complex with either PEI or the PEI-Ab conjugates. After 48 hours of transfection, both cells were subjected to a second immunostaining with PE-conjugated antivimentin antibodies (i.e., red fluorescence labeled), which allowed us to distinguish HEC-1A cells from stromal cells based on the fluorescence. As illustrated in Figure 6 , more cells were green fluorescent when the PEI-Ab conjugates were the gene carriers, as compared to PEI (compare Fig.  6B and 6E), suggesting that the PEI-Ab conjugates gain a preference for cancer cells. Moreover, most green fluorescent cells were vimentinnegative (compare Fig. 6E and 6F ), suggesting that HEC-1A cells, not stromal cells, are more readily transfected by the PEI-Ab/pEGFP-N3 complexes.
DISCUSSION
As a polycation, PEI has recently been utilized successfully as a vehicle for gene delivery. PEI will spontaneously adhere to and condense DNA to form compact complexes, which are readily endocytosed by various cell types. Further, PEI confers its specific targeting capability by means of a covalent coupling to various ligands, which could facilitate specific gene deliveries, such as ligand-mediated endocytosis. In this report, we describe a novel PEI-based gene delivery vector, which is applicable for cancer therapy, particularly enhancing its specific delivery of DNA toward cancer cells by targeting MMP-2 present on the surface of invading cancer cells. The use of PEI-antibody conjugates has been described previously to enhance the targeted gene delivery to antigen-bearing cells. 11, 13, 17, 23 We have also exploited the use of antibodies for cell targeting by developing a procedure for the conjugate formation between PEI and antibodies, and examined some of the biophysical properties of the resulting PEI-Ab conjugates with respect to their sizes and surface potentials. By dynamic light scattering, the sizes of commercially available 25-kDa branched PEI used and the PEI-Ab conjugates generated were estimated to be approximately 615 and 1100 nm, respectively, in a physiologic salt solution, exhibiting about a 1.8-fold increase in size upon conjugate formation. The DNA complexes of the cationic polymers were generated in a physiologically relevant condition at various N/P ratios. As expected, the diameters of PEI/DNA and the PEI-Ab/DNA were decreased as the N/P ratios were increased, with asymptotic values of 260 and 280 nm, respectively. The asymptotic reduction in size observed with PEI-Ab/DNA complexes is in general accord with previous findings. Tang et al. 22 demonstrated that the size of the DNA complexes of the branched PEI of 25 kDa generated in a physiologic salt condition at the N/P ratios of 1 or higher were less than 1000 nm in diameter, whereas Wightman et al. 14 demonstrated that particles of average sizes ranging from 100 to 400 nm were generated between DNA and branched PEI of 25 kDa in a physiologic salt condition. A further study with dynamic light scattering dem- onstrated that the 25-kDa PEI-Ab/DNA complexes prepared in 150 mM of NaCl revealed a rather homogeneous population of compact spherical particles, whose average sizes were decreased from about 1,000 to 50-100 nm as the N/P ratio was increased from 2 to 5, respectively, suggesting a strong dependency of the size of polycation/DNA complexes on their N/P ratios. 13 The high N/P ratio-driven condensation of polycation/DNA complexes has been attributed to enhanced electrostatic interactions between positively charged primary amines and DNA phosphates. 22 The surface charges of the DNA complexes of PEI or the PEI-Ab conjugates were estimated from a measurement of zeta potential. As expected, the zeta potentials were strongly negative at low N/P ratios, which were increased asymptotically to positive values along with the N/P ratios for both PEI/DNA and the PEI-Ab/DNA complexes. Cationic polymers possess high binding affinity to DNA, and so, can associate with DNA in excess of a 1:1 charge ratio; hence, strongly positive zeta potential can be observed. Many cationic polymers demonstrated their maximum transfection activities at charge ratios with an excess of primary amines to DNA phosphates. 13, 14 
CONCLUSIONS
Since producing antibodies against virtually any cell-surface molecules becomes feasible, an antibody-based targeting system has been recently studied. 23, 24 Modification of PEI or addition of antibodies to PEI could enhance targetcell recognition and the cellular importation of the delivered DNA. The results shown in our study demonstrate that such rational modifications of PEI indeed lead to improved transfection efficiencies. The high transfection efficiency of the PEI-anti-MMP-2 antibody conjugates toward HEC-1A cells was ascertained in vitro in two ways: First, the ability of the PEI-anti-MMP-2 antibody conjugates to specifically bind HEC-1A cells over stromal cells was clearly demonstrated by the YOYO-1 labeling experiment; second, a double fluorescence labeling experiment, which allowed for distinguishing HEC-1A cells from stromal cells, further verified the endometrial cancer-cell-specific transfection of GFP genes. Although further evidence might be needed for the full authenticity of the PEI-anti-MMP-2 antibody toward the endometrial cancer targeting (i.e., by using immunocytochemistry or electron microscopy) and further development must be carried out accordingly, it suffices to say, at this point, that the next step would be the application of this model system in vivo. While many obstacles may appear during the transformation from in vitro to in vivo, the PEI-employed strategy to improve the transfection efficiency and specificity could be widely applied to the novel drug delivery system.
